Interview: Oussama Badad: Chief Scientific Officer: Growmics

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Latest News

New Menopause Guide Unlocks the Power of Major Cannabinoids

HCN News Team2026-09-28T08:36:04-08:00September 28th, 2026|

HONOLULU – As demand for Cannabis and hemp-based wellness products aimed at midlife women continues to grow, a new comprehensive guide by Rare Cannabinoid Company is pushing back against the one-size-fits-all framing that has come ...

Kasvu Therapeutics Raises €30M for Next Generation Neuroplasticity Drugs

HCN News Team2026-09-28T07:10:02-08:00September 28th, 2026|

HELSINKI – Kasvu Therapeutics, a three-year-old spinout from the University of Helsinki, closed a €30 million Series A to advance its lead compound toward clinical development. The round was led by Hadean Ventures, with participation ...

Aurora Hits Curaleaf with Regulatory Complaint Over Hostile Bid

HCN News Team2026-09-25T05:48:25-08:00September 25th, 2026|

EDMONTON – Aurora Cannabis Inc. filed an application with the Alberta Securities Commission (ASC), asking the regulator to order Curaleaf Holdings Inc. to correct several alleged deficiencies in its hostile takeover bid circular – or ...